Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
Trial record 1 of 4 for:    atomoxetine and Mild cognitive impairment
Previous Study | Return to List | Next Study

Effects of Atomoxetine in Mild Cognitive Impairment (ATX-001)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
National Institute on Aging (NIA)
Information provided by (Responsible Party):
Allan I Levey, MD, Emory University
ClinicalTrials.gov Identifier:
NCT01522404
First received: January 25, 2012
Last updated: January 3, 2017
Last verified: January 2017
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: December 2017
  Estimated Primary Completion Date: August 2017 (Final data collection date for primary outcome measure)